Please assess the completion status of the following clinical trial:

Trial Title: Acupuncture for Seasonal Allergic Rhinitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Female or male patients (aged 16-45 years) with seasonal allergic rhinitis, clinically positive and test positive (skin-prick test and/or RAST) to grass and birch pollen~* Patients with \>2 years of moderate to severe SAR~* Positive skin-prick test and/or RAST (at least class 2) results~* Visual analogue scale \>40mm and \<80 mm for SAR symptoms during the past year~* Patients must be able to complete a diary for self-evaluation of symptoms and recording use of anti-symptomatic medication~* Use of, or indication for, oral antihistamines as anti-allergic medication~* Written informed consent~Exclusion Criteria:~* Perennial SAR or other types of chronic rhinitis~* Allergic asthma and/or moderate to severe atopic dermatitis~* Active tuberculosis~* Autoimmune disorders~* Severe chronic inflammatory diseases~* History of anaphylactic reactions~* Hypersensitivity to Rescue medication or related drugs used in study related drugs~* Specific immunotherapy \>3 years~* Simultaneous participation in other clinical trials~* Serious acute or chronic organic disease or mental disorder~* Pregnancy or breast feeding~* Allergy desensitisation therapy (current, during the past two years, or planned in the next two years)~* Blood coagulation disorder and/or current use of anticoagulants~* Previous acupuncture treatment for SAR~* Any Complementary and alternative medicine treatment at the moment, in the last three months or planned in the next two years

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): verum acupuncture plus rescue medication (up to 2 doses of second-generation oral antihistamines daily (e.g. 2 x 1 cetirizine dihydrochloride/daily))
- 2 (Type: PLACEBO_COMPARATOR): minimal (sham) acupuncture plus rescue medication (up to 2 doses of second-generation oral antihistamines daily (e.g. 2 x 1 cetirizine dihydrochloride/daily))
- 3 (Type: ACTIVE_COMPARATOR): rescue medication (up to 2 doses of second-generation oral antihistamines daily (e.g. 2 x 1 cetirizine dihydrochloride/daily))alone

Based on this trial design, predict the completion outcome and termination type (if applicable).